TNXP Hedge Fund Ownership (Q1 2026)

Q: Is it too late to buy Tonix Pharmaceuticals Hldg C (TNXP) following the 2026 Q2 hedge fund 13F filings?

As of today, TNXP has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), TNXP gained -0.4% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Tonix Pharmaceuticals Hldg C (TNXP)

79 + Investors. Track Smart Money conviction in TNXP. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — TNXP

Based on 80 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q

For 6 consecutive quarters, more hedge funds added TNXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

80 hedge funds hold TNXP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +233% more funds vs a year ago

fund count last 6Q

+56 new funds entered over the past year (+233% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 66% buying

52 buying27 selling

Last quarter: 52 funds were net buyers (18 opened a brand new position + 34 added to an existing one). Only 27 were sellers (18 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~18 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 27 → 18 → 20 → 18. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 55% entered in last year

■ 2% conviction (2yr+) ■ 42% medium ■ 55% new

Only 2 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💎

Buying through price weakness — shares +32%, value +16%

Value

+16%

+32%

Last quarter: funds added +32% more shares while total portfolio value only changed +16%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.

📊

Peak discovery — momentum slowing

23 → 27 → 18 → 20 → 18 new funds/Q

New funds entering each quarter: 27 → 18 → 20 → 18. TNXP is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.

🌱

Early stage — 96% of holders entered in last year

■ 2% veterans ■ 1% 1-2yr ■ 96% new

Of 85 current holders: 82 (96%) entered in the past year, only 2 (2%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

🏆

Elite ownership — 62% AUM from top-100 funds

62% from top-100 AUM funds

30 of 79 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in TNXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

5.9

out of 10

Moderate Exit Risk

Exit risk score 5.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	79	71	11.27%
13F Shares	5M	4M	32.3%
Total Value	$70M	$60M	16.43%
New Positions	17	20	-3
Increased Positions	34	35	-1
Closed Positions	9	7	+2
Reduced Positions	15	8	+7
Total Calls	3	2	50.0%
Total Puts	3	3	-
PUT/CALL Ratio	1.0	1.5	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

11.27%

13F Shares

32.3%

Total Value

$70M

$60M

16.43%

New Positions

-3

Increased Positions

-1

Closed Positions

Reduced Positions

Total Calls

50.0%

Total Puts

PUT/CALL Ratio

1.0

1.5

Neutral

Institutional Holders (2026 Q2)

79 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TNXP. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 TNXP holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Ishara Investments LP	3.17%	338,250	$4.3M
2	Jones Hill Capital LP	1.70%	625,428	$8.0M
3	Superstring Capital Management LP	0.51%	63,648	$812K
4	Essex Investment Management Co LLC	0.28%	165,144	$2.1M
5	Legato Capital Management LLC	0.06%	55,620	$710K
6	Quarry LP	0.04%	41,250	$526K
7	Point72 Asset Management, L.P.	0.02%	1,166,752	$14.9M
8	SJS Investment Consulting Inc.	0.01%	10,204	$130K
9	Cornerstone National Bank & Trust Co	0.01%	3,330	$41K
10	Susquehanna Portfolio Strategies, LLC	0.01%	65,024	$830K
11	Essential Partners LLC	0.01%	1,102	$14K
12	Ieq Capital, LLC	0.01%	92,373	$1.2M
13	Trexquant Investment LP	0.00%	63,635	$812K
14	Bridgeway Capital Management, LLC	0.00%	20,000	$255K
15	Millennium Management LLC	0.00%	966,932	$12.3M
16	Aqr Capital Management LLC	0.00%	882,595	$11.3M
17	Larson Financial Group LLC	0.00%	9,725	$124K
18	Jacobs Levy Equity Management, Inc	0.00%	57,943	$739K
19	Leonteq Securities AG	0.00%	5,700	$73K
20	Great Lakes Advisors, LLC	0.00%	23,752	$303K
21	Panagora Asset Management Inc	0.00%	56,706	$724K
22	Balyasny Asset Management L.P.	0.00%	132,591	$1.7M
23	State of Wyoming	0.00%	1,567	$20K
24	Gen-Wealth Partners Inc	0.00%	533	$7K
25	Arax Advisory Partners	0.00%	17,398	$222K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Tonix Pharmaceuticals Hldg C (TNXP)

What does the Smart Money Trend signal show for TNXP?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added TNXP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TNXP?

More buyers than sellers — 66% buying: Last quarter: 52 funds were net buyers (18 opened a brand new position + 34 added to an existing one). Only 27 were sellers (18 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for TNXP holders?

Elite ownership — 62% AUM from top-100 funds: 30 of 79 holders are among the 100 largest funds by AUM, controlling 62% of total institutional value in TNXP. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TNXP?

Mostly new holders — 55% entered in last year: Only 2 funds (2%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Tonix Pharmaceuticals Hldg C (TNXP) following the 2026 Q2 hedge fund 13F filings?

As of today, TNXP has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), TNXP has gained -0.4% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Tonix Pharmaceuticals Hldg C (TNXP)

Smart Money Signals — TNXP

Buying streak — 6 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +233% more funds vs a year ago

More buyers than sellers — 66% buying

Steady new buyers — ~18 new funds per quarter

Mostly new holders — 55% entered in last year

Buying through price weakness — shares +32%, value +16%

Peak discovery — momentum slowing

Early stage — 96% of holders entered in last year

Elite ownership — 62% AUM from top-100 funds

Institutional Sentiment Summary — TNXP

Hedge Fund Ownership: TNXP

Market Analysis: TNXP

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: TNXP

Is It Too Late to Buy Tonix Pharmaceuticals Hldg C (TNXP) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: TNXP

Statistics: TNXP

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Tonix Pharmaceuticals Hldg C (TNXP)

Welcome to 13Foresight!